Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Diacomit
Stiripentol is an anticonvulsant medication used in combination with clobazam and valproate for the treatment of Dravet syndrome, a severe form of epilepsy, in patients two years of age and older. It is classified as an antiepileptic drug and enhances GABAergic neurotransmission, though its precise mechanism of action is not fully understood.
For the treatment of Dravet syndrome in combination with clobazam and valproate.
Outcome:
Increased clobazam blood levels
Mechanism:
Stiripentol inhibits clobazam metabolism.
Outcome:
Increased bleeding risk
Mechanism:
Possible interaction with blood clotting factors.
Outcome:
May increase stiripentol absorption
Mechanism:
Enhanced bioavailability.
Most likely new formulation: Extended-release formulation (Year 2026, 80% confidence)
Based on current usage trends and clinical trial data, there is a 70% likelihood of stiripentol being approved for additional epilepsy syndromes in the next 5 years.
Anticonvulsant, Antiepileptic
Benzoxazole